發(fā)布時(shí)間：2018-03-02 21:37

  本文選題：乳腺癌　切入點(diǎn)：卵巢癌　出處：《中國(guó)實(shí)用婦科與產(chǎn)科雜志》2017年04期 　論文類型：期刊論文

【摘要】：乳腺癌是女性最常見的惡性腫瘤,如有未婚未育史、家族遺傳史、三陰性乳腺癌、術(shù)后口服選擇性雌激素拮抗劑及BRCA1/BRCA2基因突變者,應(yīng)特別警惕乳腺癌術(shù)后再發(fā)卵巢癌的可能。通過基因檢測(cè)、臨床篩查及降風(fēng)險(xiǎn)輸卵管卵巢切除術(shù)(risk-reducing salpingo-oophorectomy,RRSO)的方法,可以有效預(yù)防乳腺癌術(shù)后再發(fā)卵巢癌。而對(duì)于乳腺癌術(shù)后已經(jīng)發(fā)現(xiàn)卵巢癌者,應(yīng)盡早接受治療。乳腺癌與卵巢癌的發(fā)病間隔≥5年的患者所占比例最高,提示獲得長(zhǎng)期生存的乳腺癌患者也要警惕卵巢癌的發(fā)生。
[Abstract]:Breast cancer is the most common malignant tumor in women, such as unmarried, family history, tri-negative breast cancer, oral oral selective estrogen antagonist and BRCA1/BRCA2 gene mutation. Special attention should be paid to the possibility of recurrence of ovarian cancer after breast cancer surgery. The method of risk-reducing salpingo-oophorectomy and RRSO) should be used in gene screening, clinical screening and fallopian tube ovariectomy. Can effectively prevent recurrence of ovarian cancer after breast cancer. For those who have found ovarian cancer after breast cancer, we should receive treatment as soon as possible. The proportion of patients with breast cancer and ovarian cancer with a interval of 鈮，

本文編號(hào)：1558178